Last update:

Clinical pharmacology news

Experimental anesthetic may also blunt pain at nonsedating doses

Common intravenous anesthetics such as propofol and etomidate usually require additional pain medicines. Propofol and etomidate enhance GABA-A receptors, which act as brakes on nerve-cell activity, but generally do not relieve ...

Can psychedelics improve decision-making?

For the one-in-five Americans with a mental health condition, the options for treatment aren't too much different from what they were half a century ago. Most medicines for psychiatric disorders were first pioneered in the ...

Molecular glues: Unlocking new targets in cancer

The human genome encodes several hundred E3 ligases—the enzymes that decide which proteins a cell destroys. Drug developers have so far harnessed a small number of them. In a new review in Molecular Cell, researchers at Karolinska ...

Neurosteroid offers clues to brain changes linked to depression

UT Southwestern Medical Center researchers and colleagues, including two at UT Dallas, have found evidence that pregnenolone—a naturally occurring steroid hormone the body produces from cholesterol—may alter patterns of communication ...

Can a small DNA fix protect against Parkinson's disease?

In 2021, researchers at Oslo University Hospital discovered that by switching off a specific gene in the roundworm C. elegans, they could protect a particular type of nerve cell from age-related degeneration. These are the ...

How research paved the way for progress in a rare form of ALS

An experimental ALS drug that grew out of basic and clinical research at Columbia University's Vagelos College of Physicians and Surgeons may soon become available for patients with a rare and aggressive form of the disease.

About half of drinkers on GLP-1s say they imbibed less

Nearly half of drinkers who take GLP-1 medications have reported declines in consumption, with the effect higher among those at risk of unhealthy alcohol use, a new Harvard study shows. The work, published in the journal ...

RNA-protein interactions reveal new coronavirus drug targets

A study led by researchers at the University of California San Diego School of Medicine and University of California, Riverside (UCR) School of Medicine has identified new targets for antiviral drugs against coronaviruses, ...